Carlos Camps

16.9k total citations · 3 hit papers
289 papers, 9.6k citations indexed

About

Carlos Camps is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Carlos Camps has authored 289 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Oncology, 131 papers in Pulmonary and Respiratory Medicine and 81 papers in Molecular Biology. Recurrent topics in Carlos Camps's work include Lung Cancer Treatments and Mutations (111 papers), Lung Cancer Research Studies (54 papers) and Cancer Genomics and Diagnostics (42 papers). Carlos Camps is often cited by papers focused on Lung Cancer Treatments and Mutations (111 papers), Lung Cancer Research Studies (54 papers) and Cancer Genomics and Diagnostics (42 papers). Carlos Camps collaborates with scholars based in Spain, France and United States. Carlos Camps's co-authors include Rafael Sirera, Roy M. Bremnes, Rafael Rosell, José Javier Sánchez, Eloísa Jantus‐Lewintre, Miquel Tarón, Dolores Isla, José Gómez‐Codina, Vicente Alberola and Silvia Calabuig‐Fariñas and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Carlos Camps

277 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer

1994 923 citations Carlos Camps et al. profile →
Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

2002 551 citations Carlos Camps, Manuel Dómine et al. profile →
The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer

2010 525 citations Rafael Sirera, Carlos Camps et al. profile →

Peers

Countries citing papers authored by Carlos Camps

Since Specialization

Citations

This map shows the geographic impact of Carlos Camps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Camps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Camps more than expected).

Fields of papers citing papers by Carlos Camps

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Camps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Camps. The network helps show where Carlos Camps may publish in the future.

Co-authorship network of co-authors of Carlos Camps

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Camps. A scholar is included among the top collaborators of Carlos Camps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Camps. Carlos Camps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methods 2025 ·European Radiology ·(unknown), (unknown), (unknown), Ana Jiménez-Pastor, Glen J. Weiss, Luis Martí‐Bonmatí, (unknown), (unknown), Giuseppe Luigi Banna, Alfredo Addeo, Carlos Camps, Luis Seijó, Ángel Alberich‐Bayarri	0
2	Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial 2023 ·British Journal of Cancer ·Sophie Postel‐Vinay, (unknown), Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, R. de las Peñas, (unknown), Santiago Viteri, (unknown), Ana Laura Ortega Granados, Teresa Morán, Carlos Camps, Ana López, Mariano Provencio, Jean‐Charles Soria, Benjamin Besse, Bartomeu Massutí, Rafael Rosell	4
3	Machine Learning–Assisted Recurrence Prediction for Patients With Early-Stage Non–Small-Cell Lung Cancer 2023 ·JCO Clinical Cancer Informatics ·(unknown), María Torrente, Luca Costabello, Virginia Calvo, Brian H. Walsh, Carlos Camps, Sameh K. Mohamed, Ana Laura Ortega Granados, Vít Nováček, Bartomeu Massutí, Pasquale Minervini, (unknown), E. del Barco, Joaquim Bosch‐Barrera, Ernestina Menasalvas, Mohan Timilsina, Mariano Provencio	11
4	Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer 2023 ·International Journal of Molecular Sciences ·Susana Torres‐Martínez, Silvia Calabuig‐Fariñas, (unknown), (unknown), Ester Munera-Maravilla, Rafael Sirera, Lara Navarro, Ana Blasco, Carlos Camps, Eloísa Jantus‐Lewintre	2
5	Soluble galectin‐3 as a microenvironment‐relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma 2023 ·Molecular Oncology ·Susana Torres‐Martínez, Silvia Calabuig‐Fariñas, (unknown), Giulia Bertolini, Alejandro Herreros‐Pomares, (unknown), E. Durendez-Saez, R. Guijarro, Ana Blasco, Luca Roz, Carlos Camps, Eloísa Jantus‐Lewintre	3
6	The control of carpel determinacy pathway leads to sex determination in cucurbits 2022 ·Science ·Siqi Zhang, Feng‐Quan Tan, (unknown), (unknown), Ravi Devani, Christelle Troadec, Fabien Marcel, Halima Morin, Carlos Camps, Maria Victoria Gómez Roldán, Moussa Benhamed, Catherine Dogimont, Adnane Boualem, Abdelhafid Bendahmane	50
7	Increased Quality of Life in Patients with Breakthrough Cancer Pain after Individualized Therapy: the CAVIDIOM Study 2022 ·Future Oncology ·(unknown), Josep Gumà, Gloria Marquina, Noelia Martínez-Jáñez, Emilio Esteban, Antonio Antón, (unknown), (unknown), Rafael López‐López, (unknown), (unknown), (unknown), (unknown), (unknown), Carlos Camps	3
8	Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer 2022 ·Cancers ·E. Durendez-Saez, Silvia Calabuig‐Fariñas, Susana Torres‐Martínez, (unknown), Alejandro Herreros‐Pomares, (unknown), (unknown), (unknown), R. Guijarro, Eva Serna, Cristian Suárez-Cabrera, Jesús M. Paramio, Ana Blasco, Carlos Camps, Eloísa Jantus‐Lewintre	11
9	Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer 2022 ·Cancers ·(unknown), Silvia Calabuig‐Fariñas, (unknown), Susana Torres‐Martínez, (unknown), José Ángel García, Vega Iranzo, Carlos Camps	43
10	Relation of Malnutrition and Nosocomical Infections in Cancer Patients in Hospital: An Observational Study 2022 ·Journal of Nutrition and Metabolism ·(unknown), (unknown), (unknown), (unknown), (unknown), Vega Iranzo, Javier Garrido, (unknown), Carlos Camps, (unknown)	8
11	Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients 2021 ·Cancers ·Ning Dong, (unknown), Silvia Calabuig‐Fariñas, (unknown), (unknown), Ana Blasco, Francisco Aparisi, (unknown), R. Guijarro, Rafael Sirera, Carlos Camps, Eloísa Jantus‐Lewintre	17
12	Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications 2021 ·JCO Oncology Practice ·Carlos Camps, Rafael López‐López, Antonio Antón, Enrique Aranda, Alfredo Carrato, Juan Jesús Cruz, (unknown), Eduardo Díaz‐Rubio, (unknown), Jesús García‐Foncillas, Pere Gascón, (unknown), (unknown), Vicente Guillém	1
13	Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer 2021 ·Cancers ·(unknown), (unknown), Ning Dong, Giuseppe D’Auria, Mariana Reyes‐Prieto, Alejandro Herreros‐Pomares, Silvia Calabuig‐Fariñas, E. Durendez-Saez, Francisco Aparisi, Ana Blasco, (unknown), Carlos Camps, Eloísa Jantus‐Lewintre, Rafael Sirera	34
14	dPCR application in liquid biopsies: divide and conquer 2020 ·Expert Review of Molecular Diagnostics ·(unknown), Silvia Calabuig‐Fariñas, Antònia Obrador‐Hevia, Ana Blasco, (unknown), Rafael Sirera, Carlos Camps, Eloísa Jantus‐Lewintre	23
15	A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer 2020 ·Expert Review of Molecular Diagnostics ·Susana Torres‐Martínez, Álvaro González, (unknown), Silvia Calabuig‐Fariñas, (unknown), (unknown), Rafael Sirera, Eloísa Jantus‐Lewintre, Carlos Camps	28
16	Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer 2019 ·Cell Death and Disease ·Alejandro Herreros‐Pomares, (unknown), Silvia Calabuig‐Fariñas, Rut Lucas-Domínguez, Alicia Martínez‐Romero, (unknown), Sergio Alonso, Ana Blasco, R. Guijarro, Miguel Martorell, (unknown), María‐Dolores Chiara, E. Durendez-Saez, Carolina Gandía, Jerónimo Forteza, Rafael Sirera, Eloísa Jantus‐Lewintre, Rosa Farrás, Carlos Camps	75
17	A cucurbit androecy gene reveals how unisexual flowers develop and dioecy emerges 2015 ·Science ·Adnane Boualem, Christelle Troadec, Carlos Camps, Afef Lemhemdi, Halima Morin, Marie‐Agnès Sari, (unknown), Irina Kovalski, Catherine Dogimont, Rafael Perl‐Treves, Abdelhafid Bendahmane	197
18	Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature 2015 ·BMC Urology ·Vicente Guillém, Miguel Ángel Climent, Javier Cassinello, Emilio Esteban, Daniel Castellano, J.L. González-Larriba, Pablo Maroto, Carlos Camps	1
19	microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer 2011 ·Cancer Research ·Francesca M. Buffa, Carlos Camps, Laura Winchester, Cameron Snell, Harriet E. Gee, Helen Sheldon, Marian Taylor, Adrian L. Harris, Jiannis Ragoussis	251
20	Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients 2003 ·Clinical Lung Cancer ·Carlos Camps, (unknown), Bárbara Roig, José Javier Sánchez, Cristina Queralt, (unknown), Natividad Martínez-Banaclocha, Miguel Tarón, Rafael Rosell	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact